These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2476906)

  • 1. Tetrahydrobiopterin and Parkinson's disease.
    Dissing IC; Güttler F; Pakkenberg H; Lou H; Gerdes AM; Lykkelund C; Rasmussen V
    Acta Neurol Scand; 1989 Jun; 79(6):493-9. PubMed ID: 2476906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):95-8, 126-7. PubMed ID: 2791764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
    Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
    Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
    Siirtola T; Sonninen V; Rinne UK
    Clin Neurol Neurosurg; 1975; 78(2):77-88. PubMed ID: 1222507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
    Lenman JA; Turnbull MJ; Reid A; Fleming AM
    J Neurol Sci; 1977 Jun; 32(2):219-25. PubMed ID: 874521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid.
    Nishi K; Kondo T; Narabayashi H; Takubo H; Muramoto S; Araki H
    J Neurol Sci; 1989 Aug; 92(1):65-70. PubMed ID: 2475587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.
    Moser A; Siebecker F; Vieregge P; Jaskowski P; Kömpf D
    J Neural Transm (Vienna); 1996; 103(4):421-32. PubMed ID: 9617786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced dyskinesia during the treatment of Parkinson disease--biochemical studies].
    Friedman A
    Neurol Neurochir Pol; 1985; 19(5):401-3. PubMed ID: 2421191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation.
    Fink JK; Ravin P; Argoff CE; Levine RA; Brady RO; Hallett M; Barton NW
    Neurology; 1989 Oct; 39(10):1393-5. PubMed ID: 2477772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF-changes of HVA and 5-HIAA during intermittent and continuous Parkinson therapy with particular regard to prodipin application.
    Oppel F; Schulze G
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):76-80. PubMed ID: 347467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):223-6. PubMed ID: 6790255
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
    Martinez-Campos A; Giovannini P; Parati E; Novelli A; Caraceni T; Müller EE
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1116-23. PubMed ID: 7334406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
    Stefani A; Pierantozzi M; Olivola E; Galati S; Cerroni R; D'Angelo V; Hainsworth AH; Saviozzi V; Fedele E; Liguori C
    Neurochem Int; 2017 May; 105():58-63. PubMed ID: 28108196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA; Gachoud JP
    Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.
    Cheng FC; Kuo JS; Chia LG; Dryhurst G
    J Neural Transm (Vienna); 1996; 103(4):433-46. PubMed ID: 9617787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of new forms of madopar in Parkinson's disease].
    Vendrova MI; Sadekov RA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.
    Chia LG; Cheng FC; Kuo JS
    J Neurol Sci; 1993 Jun; 116(2):125-34. PubMed ID: 8336158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
    Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
    Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.
    Przuntek H; Kuhn W; Kraus P
    Acta Neurol Scand Suppl; 1989; 126():153-6. PubMed ID: 2482649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group.
    Arch Neurol; 1995 Mar; 52(3):237-45. PubMed ID: 7872875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.